|
Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus Clinical research trials and Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus. Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus clinical trial. Participants frequently get the best healthcare available for their Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus  Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
For Condition: Diabetes Mellitus,Healthy
Status: Completed
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: Type 1 diabetes mellitus is an autoimmune disease in which the body's immune cells attack the insulin-producing cells of the pancreas. Several environmental and genetic factors may predispose individuals to developing this disease, including changes in a gene called CD152. This study will examine how this gene may influence the development of insulin-dependent diabetes. Patients with Type 1 diabetes mellitus enrolled in clinical trials at the National Institutes of Health and at the University of Florida and healthy normal volunteers may participate in this study. Participants will have up to three blood samples drawn over a period of less than 1 year. The first sample (about 20 milliliters, or 4 teaspoons), will be examined for changes in the structure of the CD152 gene. If the CD152 structure is different from that normally seen in the general population, a second sample (about 90 ml, or 6 tablespoons of blood) will be drawn. This sample will be used to study the function of specialized immune system cells (T cells), including their growth and survival, chemicals they produce when stimulated, and other factors. If these cells function differently from what is generally seen in the population, a third sample (90 ml) will be drawn for more detailed studies. This investigation may help explain what makes certain individuals susceptible to Type 1 diabetes mellitus and may contribute to the development of improved treatments for the disease.
Details: Genetic variations in CD152 have been reported to confer susceptibility to the development of type-1-diabetes mellitus (T1DM). In this protocol we will draw blood samples from patients and normal control volunteers in order to analyze for the presence of CD152 genetic variations and to determine whether those variations are associated with measurable abnormalities in T cell function. Subjects with T1DM and homozygous CD152 gene polymorphisms, patients with T1DM but without CD152 polymorphisms, and control subjects with or without CD152 polymorphisms will be studied to determine whether the CD152 polymorphisms have measurable effects on T cell function and signaling. We will assess T cell function by measuring: proliferation, viability, apoptosis, cytokine production and T cell signal transduction. The identification and characterization of genes that are linked to T1DM may provide an explanation into the mechanisms by which individuals are predisposed to T1DM.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients must have a willingness and legal ability to give consent, or permission. Candidates with T1DM or Healthy Volunteers will be eligible. Patients must be equal to or greater than 18 years of age. Patients must not have an active malignancy. Patients with a hemoglobin count of less than 9.0 mg/dl will be excluded. Patients may be on erythropoietin therapy, but will not be placed on therapy solely to facilitate research sample acquisition. Patients must not have a known immunodeficiency syndrome.
Total Enrollment: 9999
Location and Contact Information:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 000063; 00-DK-0063
Study Start Date: January 20, 2000
Record last reviewed: February 28, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001985
Other Diabetes Mellitus Studies:
1. Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)
2. Periodontal Care and Glycemic Control in Diabetes
3. Krypton-Argon Regression of Neovascularization Study (KARNS)
4. Compare blood sugar level between Lantus in the morning and other insulins in Type 1 diabetes adolescents
5. Potential Risk Factors for Stroke
Related Studies:
Other Diabetes Mellitus Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
|
|
|
|
|
|
|
|
